Bank of New York Mellon’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.4M | Sell |
|
|||||
|
2025
Q2 | $11.1M | Sell |
|
|||||
|
2025
Q1 | $50.5M | Sell |
|
|||||
|
2024
Q4 | $261M | Buy |
|
|||||
|
2024
Q3 | $265M | Sell |
|
|||||
|
2024
Q2 | $337M | Buy |
|
|||||
|
2024
Q1 | $268M | Sell |
|
|||||
|
2023
Q4 | $225M | Sell |
|
|||||
|
2023
Q3 | $304M | Buy |
|
|||||
|
2023
Q2 | $279M | Buy |
|
|||||
|
2023
Q1 | $264M | Sell |
|
|||||
|
2022
Q4 | $258M | Buy |
|
|||||
|
2022
Q3 | $208M | Sell |
|
|||||
|
2022
Q2 | $149M | Buy |
|
|||||
|
2022
Q1 | $154M | Sell |
|
|||||
|
2021
Q4 | $181M | Buy |
|
|||||
|
2021
Q3 | $181M | Sell |
|
|||||
|
2021
Q2 | $154M | Buy |
|
|||||
|
2021
Q1 | $134M | Buy |
|
|||||
|
2020
Q4 | $219M | Buy |
|
|||||
|
2020
Q3 | $179M | Sell |
|
|||||
|
2020
Q2 | $208M | Buy |
|
|||||
|
2020
Q1 | $111M | Sell |
|
|||||
|
2019
Q4 | $149M | Sell |
|
|||||
|
2019
Q3 | $89.5M | Buy |
|
|||||
|
2019
Q2 | $147M | Buy |
|
|||||
|
2019
Q1 | $102M | Buy |
|
|||||
|
2018
Q4 | $62.3M | Buy |
|
|||||
|
2018
Q3 | $45M | Buy |
|
|||||
|
2018
Q2 | $36.4M | Sell |
|
|||||
|
2018
Q1 | $23.5M | Sell |
|
|||||
|
2017
Q4 | $17.7M | Buy |
|
|||||
|
2017
Q3 | $14.3M | Buy |
|
|||||
|
2017
Q2 | $8.7M | Buy |
|
|||||
|
2017
Q1 | $7.34M | Buy |
|
|||||
|
2016
Q4 | $6.75M | Buy |
|
|||||
|
2016
Q3 | $15M | Buy |
|
|||||
|
2016
Q2 | $4.23M | Buy |
|
|||||
|
2016
Q1 | $4.29M | Buy |
|
|||||
|
2015
Q4 | $8.42M | Buy |
|
|||||
|
2015
Q3 | $6.56M | Sell |
|
|||||
|
2015
Q2 | $7.35M | Buy |
|
|||||
|
2015
Q1 | $3.03M | Buy |
|
|||||
|
2014
Q4 | $3.02M | Sell |
|
|||||
|
2014
Q3 | $4.54M | Buy |
|
|||||
|
2014
Q2 | $5.99M | Sell |
|
|||||
|
2014
Q1 | $5M | Buy |
|
|||||
|
2013
Q4 | $3.63M | Buy |
|
|||||
|
2013
Q3 | $8.04M | Buy |
|
|||||
|
2013
Q2 | $6.32M | Buy |
|